Spending to Save: The Subscription Model for Eradicating Hepatitis C in Louisiana
The authors would like to thank Grant Kovel for providing excellent research assistance and seminar participants at the BU-Harvard-MIT Health Economics seminar, the Highland Health Economics Symposium, the Murphy Institute Health Policy Working Group seminar, Fiona Scott Morton, David Bradford, Liran Einav, Luca Maini, Mark Shepard, Anirban Basu, Bob Rebitzer and Jim Rebitzer, and Rebekah Gee for helpful comments. The authors thank Murray Aitken and the Iqvia Institute for Human Data Science for access to National Sales Perspective (NSP) and Longitudinal Prescription Claims (LRx) data. This content is the sole responsibility of the authors and does not represent the official views of the Louisiana Department of Health, the Iqvia Institute for Human Data Science, or the National Bureau of Economic Research.
Jacob Wallace receives financial support from the Yale School of Public Health (salary) and he or his team receive grant funding from Arnold Ventures, the National Heart, Lung, and Blood Institute, the National Institute of Drug Abuse, the Commonwealth Fund, the Robert Wood Johnson Foundation, and the Connecticut Project. He received consulting fees from KPMG to serve on an academic advisor group for California Medicaid and is an unpaid member of the New York State Department of Health’s Evidence-Based Benefit Review and Advisory Committee.
